Product Description

Mounjaro is a once-weekly- subcutaneous injection that contains tirzepatide- a dual GIP/GLP-1 receptor agonist. The 12.5 mg strength is commonly used as the third dose. The pre-filled- single-use pen is designed for at-home administration with a simple- discreet injection experience when used exactly as prescribed - 1 Pen